Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: blankmind who wrote (5602)	2/22/1998 5:22:00 PM
From: RT	Read Replies (2) \| Respond to of 23519

blankmind, If you are an accountant then you of all people should understand my post. It was written in plain English and it's contents speak for themselves. I neither called Vivus a fraud, nor disputed their posted revenues. What I am pointing out is that the refill count looks very weak. In the long run it will be the refills that will determine the success of Vivus. Would you like to explain to me how is it that they could write roughly 500,000 scrips in the last year and only 4,800 weekly refills each week after one year? MY QUESTION TO YOU IS, WHERE ARE THE REORDERS. RT